Egyptian scientist Mona Schaalan is exploring long non-coding RNA H19 (lncRNA H19) and related microRNA (miRNA): When miRNA 200c/miRNA 139 and miRNA-204/miRNA-182 were used as novel predictors of therapeutic response in HP induced GU or PU progression to GC, it was found that lncRNA H19 (50) levels were significantly increased in GC patients compared with GU subjects. This evidence concerns the gene H19 and gastric cancer.